Detailansicht

Wissensnetz

Person

Wolfgang Miesbach

Arzt

Name	Wolfgang Miesbach
Ort	Frankfurt am Main (Wirkungsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Prof. Dr. med. (am Fachbereich Medizin der Universität Frankfurt (Main)) (1996)
Beruf	Arzt (charakteristischer Beruf)
Variante	W. Miesbach
Weitere Angaben	Habil.-Schr. am Fachbereich Medizin der Universität Frankfurt (Main), 2012
Datensatztyp	Person
GND-Nummer	1045403334
Datensatz-ID	1045403334
Beteiligt an alle anzeigen Adeno-associated viruses for gene therapy – clinical implications and liver related complications, a guide for hepatologists Gentherapeutische Konzepte in der Behandlung der Hämophilie Gentherapeutische Konzepte in der Behandlung der Hämophilie Real-world use of recombinant porcine sequence factor VIII in the treatment of acquired hemophilia A: EU PASS The management of liver disease in people with congenital bleeding disorders: guidance from European Association for Haemophilia and Allied Disorders, European Haemophilia Consortium, ISTH, and World Federation of Hemophilia Which patients should be considered for gene therapy Emicizumab for the Treatment of Acquired Hemophilia A: Consensus Recommendations from the GTH-AHA Working Group Factor XIII and Endothelial Dysfunction in Patients with Systemic Sclerosis GTH 2023: The Patient as a Benchmark Stable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapy Valoctocogen Roxaparvovec (Roctavian®) : erste Gentherapie für Erwachsene mit schwerer Hämophilie A Erratum: Gentherapie der Hämophilie: Empfehlung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) Gentherapie der Hämophilie: Empfehlung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) An Update on Laboratory Diagnostics in Haemophilia A and B Von Willebrand Disease—Specific Aspects in Women Analysis of CSF D-dimer to identify intrathecal fibrin-driven autoimmunity in patients with multiple sclerosis Die Wirksamkeit der manuellen Lymphdrainage bei Patienten mit hämophiler Arthropathie Early-onset venous thromboembolisms in newly diagnosed non-promyelocytic acute myeloid leukemia patients undergoing intensive induction chemotherapy Electronic diaries in the management of haemophilia gene therapy: Perspective of an expert group from the German, Austrian and Swiss Society on Thrombosis and Haemostasis (GTH) Gentherapie in der Hämophilie: Daten, Chancen, Herausforderungen Medikamentöse Thrombose-Prophylaxe bei ambulanten COVID-19-Patienten Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma Delivery of AAV-based gene therapy through haemophilia centres - a need for re-evaluation of infrastructure and comprehensive care: a Joint publication of EAHAD and EHC Delivery of AAV-based gene therapy through haemophilia centres - A need for re-evaluation of infrastructure and comprehensive care: A Joint publication of EAHAD and EHC Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma Endothelial function in patients with von Willebrand disease Evolution of haemophilia integrated care in the era of gene therapy: treatment centre’s readiness in United States and EU Intracranial hemorrhage in newly diagnosed non-promyelocytic acute myeloid leukemia patients admitted for intensive induction chemotherapy Mild acquired factor XIII deficiency and clinical relevance at the ICU - a retrospective analysis Neurosurgical considerations regarding decompressive craniectomy for intracerebral hemorrhage after SARS-CoV-2-vaccination in vaccine induced thrombotic thrombocytopenia-VITT Translating the success of prophylaxis in haemophilia to von Willebrand disease Diagnostik und Therapie des Antiphospholipidsyndroms Evaluation of a rapid turn-over, fully-automated ADAMTS13 activity assay: a method comparison study Gerinnungsmanagement in der gastroenterologischen Akut- und Intensivmedizin Pathological Role of Angiotensin II in Severe COVID-19 Älter werden mit Hämophilie Biomarkers and immunological parameters in haemophilia and rheumatoid arthritis patients: a comparative multiplexing laboratory study COVID-19: coagulopathy, risk of thrombosis, and the rationale for anticoagulation Evaluation of a rapid turn-over, fully-automated ADAMTS13 activity assay: a method comparison study Long‐term analysis of the benefit of prophylaxis for adult patients with severe or moderate haemophilia A Perioperative management for patients with von Willebrand disease: Defining the optimal approach Prospective evaluation of the pre-, intra-, and postoperative kinetics of ADAMTS-13, von Willebrand factor, and interleukin-6 in vascular surgery Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study Leitlinie der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) zur Struktur- und Prozessqualität von Hämophilie-Zentren Replacement Therapy in Patients with Von Willebrand Disease—Indications and Monitoring Long-Term Safety and Efficacy Data of a Plasma-Derived Factor VIII Concentrate with von Willebrand Factor for Treatment of Patients with Hemophilia A Covering 18 Years The Course of von Willebrand Factor and Factor VIII Activity in Patients with von Willebrand Disease during Pregnancy Älter werden mit Hämophilie Gerinnungsfaktoren mit verlängerter Halbwertszeit : Erfahrungsberichte mit Elocta und Alprolix bei Hämophilie A und B How to discuss gene therapy for haemophilia? A patient and physician perspective Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study Platelet aggregation testing on a routine coagulation analyzer: a method comparison study Endothelial Function in Patients with Severe and Moderate Haemophilia A and B Is gingival bleeding a symptom of type 2 and 3 von Willebrand disease? Multiple thrombophile Risikomarker bei Patienten ≺65 Jahre mit venösen retinalen Gefäßverschlüssen Prävalenz erhöhter Lipoprotein(a)-Spiegel bei unter 60-jährigen Patienten mit venösen retinalen Gefäßverschlüssen Differential kinetics of coagulation factors and natural anticoagulants in patients with liver cirrhosis: potential clinical implications Biomimetic biosensor to distinguish between inhibitory and non-inhibitory factor VIII antibodies Kardiale und zerebrale Manifestationen bei Antiphospholipid-Syndrom

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Wolfgang Miesbach

Adeno-associated viruses for gene therapy – clinical implications and liver related complications, a guide for hepatologists

Gentherapeutische Konzepte in der Behandlung der Hämophilie

Gentherapeutische Konzepte in der Behandlung der Hämophilie

Real-world use of recombinant porcine sequence factor VIII in the treatment of acquired hemophilia A: EU PASS

The management of liver disease in people with congenital bleeding disorders: guidance from European Association for Haemophilia and Allied Disorders, European Haemophilia Consortium, ISTH, and World Federation of Hemophilia

Which patients should be considered for gene therapy

Emicizumab for the Treatment of Acquired Hemophilia A: Consensus Recommendations from the GTH-AHA Working Group

Factor XIII and Endothelial Dysfunction in Patients with Systemic Sclerosis

GTH 2023: The Patient as a Benchmark

Stable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapy

Valoctocogen Roxaparvovec (Roctavian®) : erste Gentherapie für Erwachsene mit schwerer Hämophilie A

Erratum: Gentherapie der Hämophilie: Empfehlung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH)

Gentherapie der Hämophilie: Empfehlung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH)

An Update on Laboratory Diagnostics in Haemophilia A and B

Von Willebrand Disease—Specific Aspects in Women

Analysis of CSF D-dimer to identify intrathecal fibrin-driven autoimmunity in patients with multiple sclerosis

Die Wirksamkeit der manuellen Lymphdrainage bei Patienten mit hämophiler Arthropathie

Early-onset venous thromboembolisms in newly diagnosed non-promyelocytic acute myeloid leukemia patients undergoing intensive induction chemotherapy

Electronic diaries in the management of haemophilia gene therapy: Perspective of an expert group from the German, Austrian and Swiss Society on Thrombosis and Haemostasis (GTH)

Gentherapie in der Hämophilie: Daten, Chancen, Herausforderungen

Medikamentöse Thrombose-Prophylaxe bei ambulanten COVID-19-Patienten

Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma

Delivery of AAV-based gene therapy through haemophilia centres - a need for re-evaluation of infrastructure and comprehensive care: a Joint publication of EAHAD and EHC

Delivery of AAV-based gene therapy through haemophilia centres - A need for re-evaluation of infrastructure and comprehensive care: A Joint publication of EAHAD and EHC

Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma

Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma

Endothelial function in patients with von Willebrand disease

Evolution of haemophilia integrated care in the era of gene therapy: treatment centre’s readiness in United States and EU

Intracranial hemorrhage in newly diagnosed non-promyelocytic acute myeloid leukemia patients admitted for intensive induction chemotherapy

Mild acquired factor XIII deficiency and clinical relevance at the ICU - a retrospective analysis

Neurosurgical considerations regarding decompressive craniectomy for intracerebral hemorrhage after SARS-CoV-2-vaccination in vaccine induced thrombotic thrombocytopenia-VITT

Translating the success of prophylaxis in haemophilia to von Willebrand disease

Diagnostik und Therapie des Antiphospholipidsyndroms

Evaluation of a rapid turn-over, fully-automated ADAMTS13 activity assay: a method comparison study

Gerinnungsmanagement in der gastroenterologischen Akut- und Intensivmedizin

Pathological Role of Angiotensin II in Severe COVID-19

Älter werden mit Hämophilie

Biomarkers and immunological parameters in haemophilia and rheumatoid arthritis patients: a comparative multiplexing laboratory study

COVID-19: coagulopathy, risk of thrombosis, and the rationale for anticoagulation

Evaluation of a rapid turn-over, fully-automated ADAMTS13 activity assay: a method comparison study

Long‐term analysis of the benefit of prophylaxis for adult patients with severe or moderate haemophilia A

Perioperative management for patients with von Willebrand disease: Defining the optimal approach

Prospective evaluation of the pre-, intra-, and postoperative kinetics of ADAMTS-13, von Willebrand factor, and interleukin-6 in vascular surgery

Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study

Leitlinie der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) zur Struktur- und Prozessqualität von Hämophilie-Zentren

Replacement Therapy in Patients with Von Willebrand Disease—Indications and Monitoring

Long-Term Safety and Efficacy Data of a Plasma-Derived Factor VIII Concentrate with von Willebrand Factor for Treatment of Patients with Hemophilia A Covering 18 Years

The Course of von Willebrand Factor and Factor VIII Activity in Patients with von Willebrand Disease during Pregnancy

Älter werden mit Hämophilie

Gerinnungsfaktoren mit verlängerter Halbwertszeit : Erfahrungsberichte mit Elocta und Alprolix bei Hämophilie A und B

How to discuss gene therapy for haemophilia? A patient and physician perspective

Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study

Platelet aggregation testing on a routine coagulation analyzer: a method comparison study

Endothelial Function in Patients with Severe and Moderate Haemophilia A and B

Is gingival bleeding a symptom of type 2 and 3 von Willebrand disease?

Multiple thrombophile Risikomarker bei Patienten ≺65 Jahre mit venösen retinalen Gefäßverschlüssen

Prävalenz erhöhter Lipoprotein(a)-Spiegel bei unter 60-jährigen Patienten mit venösen retinalen Gefäßverschlüssen

Differential kinetics of coagulation factors and natural anticoagulants in patients with liver cirrhosis: potential clinical implications

Biomimetic biosensor to distinguish between inhibitory and non-inhibitory factor VIII antibodies

Kardiale und zerebrale Manifestationen bei Antiphospholipid-Syndrom